L

Life Science REIT PLC
LSE:LABS

Watchlist Manager
Life Science REIT PLC
LSE:LABS
Watchlist
Price: 38.8 GBX 0.52% Market Closed
Market Cap: £135.8m

Multiples-Based Value

The Multiples-Based Value of one LABS stock under the Base Case scenario is 9.77 GBX. Compared to the current market price of 38.8 GBX, Life Science REIT PLC is Overvalued by 75%.

Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

LABS Multiples-Based Value
Base Case
9.77 GBX
Overvaluation 75%
Multiples-Based Value
Price
L
Worst Case
Base Case
Best Case

Multiples Across Competitors

LABS Competitors Multiples
Life Science REIT PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
Life Science REIT PLC
LSE:LABS
135.8m GBP 6.5 -4.4 12.5 12.5
US
Welltower Inc
NYSE:WELL
136.4B USD 12.6 145.5 62.2 472
US
Ventas Inc
NYSE:VTR
38.9B USD 6.7 154.7 21.2 51.8
US
Omega Healthcare Investors Inc
NYSE:OHI
13.2B USD 11 22.9 16.2 23.3
US
Physicians Realty Trust
NYSE:DOC
11.5B USD 4.1 164 12.8 37.8
US
Healthpeak Properties Inc
F:HC5
10.1B EUR 4.2 167.5 13 38.2
US
CareTrust REIT Inc
NYSE:CTRE
8.3B USD 17.4 25.8 21.6 27.9
BE
Aedifica NV
XBRU:AED
5.7B EUR 9.1 14.3 26.9 27.2
US
Healthcare Trust Of America Inc
F:HT01
5.3B EUR 8 66.4 20.1 51.7
US
Healthcare Realty Trust Inc
NYSE:HR
5.9B USD 5 -23.8 15 104.1
US
Sabra Health Care REIT Inc
NASDAQ:SBRA
4.9B USD 6.4 31.7 16.5 28.2
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett